Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model

M Lazzarini, S Martin, M Mitkovski, RR Vozari… - Glia, 2013 - Wiley Online Library
Neuron–glia interactions play a key role in maintaining and regulating the central nervous
system. Glial cells are implicated in the function of dopamine neurons and regulate their …

Minocycline inhibits LPS-induced retinal microglia activation

AL Wang, CH Albert, LT Lau, C Lee, MOM Tso - Neurochemistry …, 2005 - Elsevier
Retinal neurodegenerative disease involves an inflammatory response in the retina
characterized by an increase in inflammatory cytokines and activation of microglia. The …

Imaging microglial activation in Huntington's disease

YF Tai, N Pavese, A Gerhard, SJ Tabrizi, RA Barker… - Brain research …, 2007 - Elsevier
Activated microglia have been proposed to play a major role in the pathogenesis of
Huntington's Disease (HD). PK11195 is a ligand which binds selectively to peripheral …

Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice

JE Davies, L Wang, L Garcia-Oroz, LJ Cook… - Nature medicine, 2005 - nature.com
The muscular dystrophies are a heterogeneous group of disorders for which there are
currently no cures. Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant …

Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease

W Noble, C Garwood, J Stephenson… - The FASEB …, 2009 - Wiley Online Library
Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles of
hyperphosphorylated, aggregated tau protein and extracellular deposits of β‐amyloid …

The potential of minocycline for neuroprotection in human neurologic disease

D Zemke, A Majid - Clinical neuropharmacology, 2004 - journals.lww.com
Minocycline is a member of the tetracycline class of molecules with broad-spectrum
antibiotic activity. The unique properties of minocycline result in increased tissue distribution …

[HTML][HTML] Neuroprotective effects of doxycycline in the R6/2 mouse model of Huntington's disease

E Paldino, C Balducci, P La Vitola, L Artioli… - Molecular …, 2020 - Springer
Mechanisms of tissue damage in Huntington's disease involve excitotoxicity, mitochondrial
damage, and inflammation, including microglia activation. Immunomodulatory and anti …

A new face for old antibiotics: tetracyclines in treatment of amyloidoses

T Stoilova, L Colombo, G Forloni… - Journal of medicinal …, 2013 - ACS Publications
The use of tetracyclines has declined because of the appearance of resistant bacterial
strains. However, the indications of nonantimicrobial activities of these drugs have …

Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease

X Wang, S Zhu, Z Pei, M Drozda… - Journal of …, 2008 - Soc Neuroscience
Release of mitochondrial cytochrome c resulting in downstream activation of cell death
pathways has been suggested to play a role in neurologic diseases featuring cell death …

[HTML][HTML] Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies

MM Evers, LJA Toonen, WMC van Roon-Mom - Molecular neurobiology, 2014 - Springer
Ataxin-3 is a ubiquitously expressed deubiqutinating enzyme with important functions in the
proteasomal protein degradation pathway and regulation of transcription. The C-terminus of …